Kupatt, C.* et al. Genome editing for Duchenne muscular dystrophy: A glimpse of the future? Gene Ther. 28, 542–548 (2021)
Rollier, C.S.* et al. T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates. Gene Ther. 23, 753-759 (2016)
Pfeifer, C.* ; Aneja, M.K. ; Hasenpusch, G.* & Rudolph, C.* Adeno-associated virus serotype 9-mediated pulmonary transgene expression: effect of mouse strain, animal gender and lung inflammation. Gene Ther. 18, 1034-1042 (2011)
Pike, L.S.* et al. Imaging gene delivery in a mouse model of congenital neuronal ceroid lipofuscinosis. Gene Ther. 18, 1173-1178 (2011)
Westermann, J.* et al. Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: A clinical phase-I study. Gene Ther. 18, 354-363 (2011)
Kutscher, S. et al. MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays. Gene Ther. 17, 1372-1383 (2010)
Riddell, S.R.* & Protzer, U. Grafting chimeric antigen receptors to redirect T cells: Carving the CAR. Gene Ther. 17, 1191-1192 (2010)
Bauer, M. et al. Prevention of interferon-stimulated gene expression using microRNA-designed hairpins. Gene Ther. 16, 142-147 (2009)
Rothenaigner, I. ; Kramer, S. ; Meggendorfer, M. ; Rethwilm, A.* & Brack-Werner, R. Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression. Gene Ther. 16, 349-358 (2009)
Hellebrand, E. et al. Epstein-Barr virus vector-mediated gene transfer into human B cells: Potential for antitumor vaccination. Gene Ther. 13, 150-162 (2006)
Hettich, E. et al. Genetic design of an optimized packaging cell line for gene vectors transducing human B cells. Gene Ther. 13, 844-856 (2006)
Kofler, D.M. et al. Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors. Gene Ther. 11, 1416-1424 (2004)
Buning, H.* et al. Receptor targeting of adeno-associated virus vectors. Gene Ther. 10, 1142-1151 (2003)
Schendel, D.J. et al. Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity. Gene Ther. 7, 2-10 (2000)
Selmayr, M. et al. Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype. Gene Ther. 6, 778-784 (1999)